Search results
Humira: the highs and lows of the world’s best-selling drug
Pharmaceutical Technology via Yahoo Finance· 6 days agoHumira, an arthritis medication with indications for colitis and psoriasis is the world’s...
Gateway - Quartz
Quartz· 6 days agoHumira, a monoclonal antibody used to treat arthritis among other conditions, is the most lucrative drug in history. Since entering the market in 2003, it has made its manufacturer ...
2 Super Smart Dividend Stocks to Buy With $10,000 Right Now
Motley Fool via Yahoo Finance· 5 days agoHere are a couple of investment suggestions, whether it's $10,000 or much more or less. AbbVie Most...
FDA Plans to Ease Requirements for Biosimilars' Interchangeable Status
MedPage Today· 4 days agoThe FDA on Thursday announced that biosimilars seeking an interchangeable status would no longer require studies showing that switching between a biosimilar and its branded reference product ...
Gilead says its HIV prevention shot was 100% effective in a clinical trial
Quartz· 4 days agoGilead announced that its twice-yearly injection lenacapavir worked with 100% efficacy at preventing...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks via Yahoo Finance· 5 days agoSkyrizi and AbbVie’s another inflammatory disease drug Rinvoq are performing extremely well,...
239 Shares in AbbVie Inc. (NYSE:ABBV) Bought by Ables Iannone Moore & Associates Inc.
ETF DAILY NEWS· 6 days agoAbles Iannone Moore & Associates Inc. bought a new stake in AbbVie Inc. (NYSE:ABBV – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities ...
Modus Advisors LLC Acquires 450 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 5 days agoModus Advisors LLC raised its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 2.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities ...
Psoriatic Arthritis Drugs Comparably Improve Joint Outcomes
Medscape· 5 days agoReal-world study data suggest there is little difference among five drug classes commonly used to...
Canandaigua National Bank & Trust Co. Trims Holdings in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 5 days agoCanandaigua National Bank & Trust Co. reduced its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 3.1% in the 1st quarter, according to the company in its most recent 13F filing ...